Qingsong Lu, Xiaozhen Zhang, Tingbo Liang, & Xueli Bai. (2022). O-GlcNAcylation: An important post-translational modification and a potential therapeutic target for cancer therapy. BMC.
Chicago Style (17th ed.) CitationQingsong Lu, Xiaozhen Zhang, Tingbo Liang, and Xueli Bai. O-GlcNAcylation: An Important Post-translational Modification and a Potential Therapeutic Target for Cancer Therapy. BMC, 2022.
MLA (9th ed.) CitationQingsong Lu, et al. O-GlcNAcylation: An Important Post-translational Modification and a Potential Therapeutic Target for Cancer Therapy. BMC, 2022.
Warning: These citations may not always be 100% accurate.